515 related articles for article (PubMed ID: 8598368)
1. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
[TBL] [Abstract][Full Text] [Related]
2. Results of a pilot study of low-dose craniospinal radiation therapy plus chemotherapy for children younger than 5 years with primitive neuroectodermal tumors.
Goldwein JW; Radcliffe J; Packer RJ; Sutton LN; Lange B; Rorke LB; D'Angio GJ
Cancer; 1993 Apr; 71(8):2647-52. PubMed ID: 8384073
[TBL] [Abstract][Full Text] [Related]
3. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
4. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
5. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
6. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
Allen JC; Donahue B; DaRosso R; Nirenberg A
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
[TBL] [Abstract][Full Text] [Related]
8. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.
Reddy AT; Janss AJ; Phillips PC; Weiss HL; Packer RJ
Cancer; 2000 May; 88(9):2189-93. PubMed ID: 10813733
[TBL] [Abstract][Full Text] [Related]
9. Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Sawamura Y; Ikeda J; Ishii N; Kato T; Tada M; Abe H; Shirato H
Neurol Med Chir (Tokyo); 1996 Sep; 36(9):632-8. PubMed ID: 8913079
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma: clinical and biologic aspects.
Packer RJ; Cogen P; Vezina G; Rorke LB
Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
[TBL] [Abstract][Full Text] [Related]
12. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine.
Lefkowitz IB; Packer RJ; Siegel KR; Sutton LN; Schut L; Evans AE
Cancer; 1990 Feb; 65(3):412-7. PubMed ID: 2153428
[TBL] [Abstract][Full Text] [Related]
13. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
[TBL] [Abstract][Full Text] [Related]
15. Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1-3) Medulloblastoma--a safety/feasibility study.
Taylor RE; Howman AJ; Wheatley K; Brogden EE; Large B; Gibson MJ; Robson K; Mitra D; Saran F; Michalski A; Pizer BL
Radiother Oncol; 2014 Apr; 111(1):41-6. PubMed ID: 24630538
[TBL] [Abstract][Full Text] [Related]
16. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
[TBL] [Abstract][Full Text] [Related]
17. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study.
Prados MD; Edwards MS; Chang SM; Russo C; Davis R; Rabbitt J; Page M; Lamborn K; Wara WM
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):279-85. PubMed ID: 10030250
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
[TBL] [Abstract][Full Text] [Related]
19. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: early results of a pilot study.
Prados MD; Wara WM; Edwards MS; Cogen PH
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):431-8. PubMed ID: 8276658
[TBL] [Abstract][Full Text] [Related]
20. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
